C13ORF31 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.250030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.398400E-01
Normal-vs-Stage2
1.539180E-01
Normal-vs-Stage3
1.409360E-01
Normal-vs-Stage4
3.679600E-01
Stage1-vs-Stage2
4.629800E-01
Stage1-vs-Stage3
2.140000E-01
Stage1-vs-Stage4
9.657400E-01
Stage2-vs-Stage3
4.271400E-01
Stage2-vs-Stage4
5.231200E-01
Stage3-vs-Stage4
2.454600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.525900E-02
Normal-vs-AfricanAmerican
1.377960E-01
Normal-vs-Asian
1.881210E-01
Caucasian-vs-AfricanAmerican
7.624400E-01
Caucasian-vs-Asian
9.171200E-01
AfricanAmerican-vs-Asian
7.643800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.183600E-02
Normal-vs-Female
2.035400E-01
Male-vs-Female
3.327200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.327820E-01
Normal-vs-Age(41-60Yrs)
2.789800E-01
Normal-vs-Age(61-80Yrs)
8.449800E-02
Normal-vs-Age(81-100Yrs)
1.415990E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.336600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.798400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.313400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.564300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.766200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.314200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.306100E-02
Normal-vs-Daily Drinker
2.907600E-02
Normal-vs-Weekly Drinker
1.390230E-01
Normal-vs-Occasional Drinker
1.396440E-01
Normal-vs-Social Drinker
4.005400E-01
Non Drinker-vs-Daily Drinker
3.011000E-01
Non Drinker-vs-Weekly Drinker
4.128200E-01
Non Drinker-vs-Occasional Drinker
3.106800E-01
Non Drinker-vs-Social Drinker
2.536400E-01
Daily Drinker-vs-Weekly Drinker
1.376980E-01
Daily Drinker-vs-Occasional Drinker
8.661600E-02
Daily Drinker-vs-Social Drinker
7.032000E-02
Weekly Drinker-vs-Occasional Drinker
9.172400E-01
Weekly Drinker-vs-Social Drinker
6.255400E-01
Occasional Drinker-vs-Social Drinker
6.549600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.444400E-01
Normal-vs-Grade 2
1.754820E-01
Normal-vs-Grade 3
2.714400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.395200E-01
Grade 1-vs-Grade 3
3.020000E-01
Grade 1-vs-Grade 4
5.444400E-01
Grade 2-vs-Grade 3
8.945800E-01
Grade 2-vs-Grade 4
1.754820E-01
Grade 3-vs-Grade 4
2.714400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.287030E-01
Normal-vs-NonDiabetic
8.943900E-02
Diabetic-vs-NonDiabetic
8.646800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.184400E-02
Normal-vs-NoPancreatitis
1.133750E-01
Pancreatitis-vs-NoPancreatitis
6.418400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.114950E-01
Normal-vs-N1
1.471440E-01
N0-vs-N1
7.651600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.499030E-01
Normal-vs-TP53-NonMutant
1.339380E-01
TP53-Mutant-vs-TP53-NonMutant
8.717800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
